Bayer
VerifiedGlobal enterprise with core competencies in the Life Science fields of health care and agriculture
Launch date
Employees
Market cap
€55.3b
Net debt
€29.6b
Firm valuation
$94.2b (Public information from 2022)
Share price
€56.27 BAYN.DE
Leverkusen Nordrhein-Westfalen (HQ)
Deals in current and previous year:
Corporate Venture Fund: Leaps by Bayer
RELATED LANDSCAPES AND LISTS
Financials
Edit| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E |
|---|---|---|---|---|---|---|---|
| Revenues | - | 35.0b | 39.6b | 43.5b | 41.4b | 43.3b | 45.4b |
| % growth | - | - | 13 % | 10 % | (5 %) | 5 % | 5 % |
| EBITDA | - | 9.3b | 9.5b | 11.5b | 11.5b | 11.2b | 12.1b |
| % EBITDA margin | - | 27 % | 24 % | 26 % | 28 % | 26 % | 27 % |
| Profit | - | 7.3b | 1.7b | 4.1b | (10.5b) | 671m | 4.8b |
| % profit margin | - | 21 % | 4 % | 9 % | (25 %) | 2 % | 10 % |
| EV / revenue | - | 2.6x | 2.3x | 2.4x | 2.0x | 2.0x | 1.9x |
| EV / EBITDA | - | 9.7x | 9.7x | 9.2x | 7.4x | 7.8x | 7.1x |
| R&D budget | 4.8b | 5.2b | 5.1b | 5.6b | - | - | - |
| R&D % of revenue | - | 15 % | 13 % | 13 % | - | - | - |
Source: Company fillings or news article
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | Spinout | ||
| N/A | N/A | IPO Not yet verified | |
| $7.6b | Acquisition Not yet verified | ||
| Total Funding | - | ||
Recent News about Bayer
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
By Country
Investments by Bayer
Edit
ACQUISITION by Bayer Feb 2016
ACQUISITION by Bayer Dec 2013
ACQUISITION by Bayer Jul 2012
ACQUISITION by Bayer Sep 2008
ACQUISITION by Bayer Feb 2016
ACQUISITION by Bayer Jun 2018
